BIO Balance Sheet

Bio-Rad Laboratories Inc - Assets, Liabilities & Stockholders' Equity

Total Assets

$10.58B

Total Liabilities

$3.12B

Shareholders' Equity

$7.45B

Cash Position

$531.80M

Assets

As of: 2025-12-31

Current Assets

Cash & Equivalents

$531.80M

Total Current Assets

$2.91B

Non-Current Assets

Total Assets

$10.58B

Liabilities & Equity

Current Liabilities

Total Current Liabilities

$517.00M

Non-Current Liabilities

Total Liabilities

$3.12B

Stockholders' Equity

Retained Earnings

$8.18B

Total Equity

$7.45B

Total Liabilities & Equity

$10.58B

Should equal Total Assets

Key Balance Sheet Ratios

Current Ratio

5.62

Current Assets / Current Liabilities

Working Capital

$2.39B

Current Assets - Current Liabilities

Balance Sheet Health

Liquidity: Strong

Current ratio of 5.62 indicates the company has ample short-term assets to cover short-term liabilities.

Cash Position: 5.0% of Assets

$531.80M in cash provides adequate financial flexibility.

View Complete Financial Analysis

Explore detailed financials, income statements, cash flows, and more

Open Full Financials

Frequently Asked Questions

What are BIO's total assets?

BIO has total assets of $10.58B, down from $9.36B in the previous period.

How much debt does BIO have?

Debt information for BIO can be found in the balance sheet.

What is BIO's cash position?

BIO has $531.80M in cash and cash equivalents, representing 5.0% of total assets.

What is BIO's stockholders' equity?

BIO's stockholders' equity is $7.45B. This represents the book value of the company and shareholder ownership stake.

What is BIO's current ratio?

BIO has a current ratio of 5.62. This means the company has $5.62 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.

How healthy is BIO's balance sheet?

BIO's balance sheet shows $10.58B in total assets, $3.12B in liabilities, and $7.45B in equity. The current ratio of 5.62 suggests strong liquidity.

Explore Categories